Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 3/2014

01-03-2014 | Childhood and Adolescent Headache (S Evers, Section Editor)

Migraine and Epilepsy in the Pediatric Population

Authors: Christopher B. Oakley, Eric H. Kossoff

Published in: Current Pain and Headache Reports | Issue 3/2014

Login to get access

Abstract

Individually, childhood epilepsy and migraine are two of the most common conditions seen in pediatric neurology. What complicates matters is that there can be marked similarities between migraine and epilepsy as well as a variety of underlying conditions that predispose children to both seizures and headache. Thus, separating epilepsy from migraine may not be easy, but can be done with a detailed history as well as timely use of ancillary testing. Once children have been diagnosed with epilepsy, migraine, or both, treatment options become essential in attempts to manage these common, yet often disabling, neurological conditions. Acute interventions tend to be condition specific while preventative options may overlap for migraine and epilepsy. In the following review, we will discuss the epidemiology of childhood epilepsy and headache, the association between them, as well as how to differentiate epilepsy from migraine. Treatment strategies will follow before concluding with a discussion on prognosis.
Literature
1.
2.•
Kelley SA, Hartman AL, Kossoff EH. Comorbidity of migraine in children presenting with epilepsy to a tertiary care center. Neurology. 2012;79:468–73. Recent prospective clinical study that correlates with other recent reports that there is a greater comorbidity between epilepsy and headache/migraine than previously indicated.PubMedCrossRef
3.•
Winawer MR, Connors R, EPGP Investigators. Evidence for a shared genetic susceptibility to migraine and epilepsy. Epilepsia. 2013;54(2):288–95. Recent cross section multicenter study of a known cohort of epilepsy patients that demonstrated higher prevalence of migraine than historical reports. Results similar to other recent reports with higher than previously noted rates of migraine in pediatric epilepsy patients. Suggesting a greater association between migraine and epilepsy than previously thought.PubMedCentralPubMedCrossRef
4.
Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52:1088–97.PubMedCrossRef
5.
6.
Sillanpää M, Saarinen M, Schmidt D. Long-term risks following first remission in childhood-onset epilepsy. A population-based study. Epilepsy Behav. 2012;25(2):145–9.PubMedCrossRef
7.•
Institute of Medicine. Epilepsy across the spectrum: promoting health and understanding. Washington, DC: The National Academy Press; 2012. Available at http://​www.​iom.​edu/​epilepsy. *Recent report that indicates epilepsy more prevalent than previously thought.
8.
Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester. Minn Epilepsia. 1991;32:429–45.CrossRef
9.
Shorvon SD, Goodridge DM Longitudinal cohort studies of the prognosis of epilepsy: contribution of the National General Practice Study of Epilepsy and other studies. Brain. 2013 Sep 24.
10.
Theodore WH, Spencer SS, Wiebe S, et al. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia. 2006;47:1700–22.PubMedCrossRef
11.
Deubner DC. An epidemiologic study of migraine and headache in 10–20 year olds. Headache. 1977;17:173–80.PubMedCrossRef
12.
Sillanpaa M. Changes in the prevalence of migraine and other headache during the first seven school years. Headache. 1983;23:15–9.PubMedCrossRef
13.
Liner MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261:2211–6.CrossRef
14.
Stewart WF, Linet MS, Celentano DD, Van Natta M, Siegler D. Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991;34:1111–20.
15.
16.
Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ. 1994;309(6957):765–9.PubMedCrossRef
17.
Dalsgaard-Nielsen T. Some aspects of the epidemiology of migraine in Denmark. Headache. 1970;10:14–23.PubMedCrossRef
18.
Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994;34:319–28.PubMedCrossRef
19.
Mortimer MJ, Kay J, Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, Vahlquist and IHS criteria. Dev Med Child Neurol. 1992;34:1095–101.PubMedCrossRef
20.
21.
Small P, Waters WE. Headache and migraine in a comprehensive school. In: Waters, editor. The epidemiology of migraine. Bracknell-Berkshire, England: Boehringer Ingel-helm, Ltd; 1974. p. 56–67.
22.
Sillanpaa M. Prevalence of migraine and other headache in Finnish children starting school. Headache. 1976;15:288–90.PubMedCrossRef
23.
Lewis DW, Ashwal S, Dahl G, Dorbad D, Hirtz D, Prensky A, et al. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002;59(4):490–8.PubMedCrossRef
24.
Dalsgaard-Nielsen T. Some aspects of the epidemiology of migraine in Denmark. Headache. 1970;10:14–23.PubMedCrossRef
25.
Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache. 2007;47:355–63.PubMed
26.
Stewart WF, Wood C, Reed ML, Roy J, Lipton RB. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008;28:1170–8.PubMedCrossRef
27.
Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses. Pediatrics. 2003;112(1 Pt 1):e1–5.PubMedCrossRef
28.
Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees with migraine. Headache. 2008;48:553–63.PubMedCrossRef
29.
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676–85.PubMedCrossRef
30.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.CrossRef
31.
Andermann E, Andermann F. Migraine-epilepsy relationships: Epidemiological and genetic aspects. In: Andermann FA, Lugaresi E, editors. Migraine and Epilepsy. Boston: Butterworths; 1987.
32.
Toldo I, Perissinotto E, Menegazzo F, et al. Comorbidity between headache and epilepsy in a pediatric headache center. J Headache Pain. 2010;11:235–40.PubMedCentralPubMedCrossRef
33.
Bigal ME, Lipton RB, Cohen J, et al. Epilepsy and migraine. Epilepsy Behav. 2003;4 suppl 2:S13–24.PubMedCrossRef
34.
35.
Stevenson SB. Epilepsy and migraine headache: Is there a connection? J Pediatr Health Care. 2005;20:167–71.CrossRef
36.•
Kanemura H, Sano F, Ishii S, Ohyama T, Sugita K, Aihara M. Characteristics of headache in children with epilepsy. Seizure. 2013;22(8):647–50. Recent prospective clinical study that correlates with other recent reports that there is a greater comorbidity between epilepsy and headache/migraine than previously indicated.PubMedCrossRef
37.
Deprez L, Peeters K, Van Paesschen W, Claeys KG, Claes LR, Suls A, et al. Familial occipitotemporal lobe epilepsy and migraine with visual aura: linkage to chromosome 9q. Neurology. 2007;68:1995–2002.PubMedCrossRef
38.
Polvi A, Siren A, Kallela M, Rantala H, Artto V, Sobel EM, et al. Shared loci for migraine and epilepsy on chromosomes 14q12–q23 and 12q24.2–q24.3. Neurology. 2012;78:202–9.PubMedCrossRef
39.
Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, Robertson R, et al. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain. 2004;127:2682–92.PubMedCrossRef
40.
Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366:371–7.PubMedCrossRef
41.
Deprez L, Weckhuysen S, Peeters K, Deconinck T, Claeys KG, Claes LR, et al. Epilepsy as part of the phenotype associated with ATP1A2 mutations. Epilepsia. 2008;49:500–8.PubMedCrossRef
42.
Lebas A, Guyant-Maréchal L, Hannequin D, Riant F, Tournier-Lasserve E, Parain D. Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation. Cephalalgia. 2008;28(7):774–7.PubMedCrossRef
43.
Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G, An- Gourfinkel I, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet. 2000;24:343–5.PubMedCrossRef
44.
Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68:1327–32.PubMedCentralPubMedCrossRef
45.
Frosk P, Mhanni AA, Rafay MF. SCN1A mutation associated with intractable myoclonic epilepsy and migraine headache. J Child Neurol. 2013;28(3):389–91.PubMedCrossRef
46.
Riant F, Ducros A, Ploton C, Banbance C, Depienne C, Tournie-Lasserve E. De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology. 2010;75:967–72.PubMedCrossRef
47.
De Fusco M, Marconi R, Silvestri L, et al. Haplo insufficiency of ATP1A2 encoding the Na+/K+ pump a2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003;33:192–6.PubMedCrossRef
48.
Vanmolkot KR, Kors EE, Hottenga JJ, Terwindt GM, Haan JJ, Hoefnagels WA. Novel mutations in the Na+/K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol. 2003;54:360–6.PubMedCrossRef
49.
50.
Wirrell EC, Hamiwka LD. Do children with benign rolandic epilepsy have a higher prevalence of migraine than those with other partial epilepsies or nonepilepsy controls? Epilepsia. 2006;47:1674–81.PubMedCrossRef
51.
Clarke T, Baskurt Z, Strug L, Pal D. Evidence of shared genetic risk factors for migraine and rolandic epilepsy. Epilepsia. 2009;50:2428–33.PubMedCrossRef
52.
Panayiotopoulos CP, Michael M, Sanders S, Valeta T, Koutroumanidis M. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain. 2008;131:2264–86.PubMedCrossRef
53.
Covanis A. Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis. Pediatrics. 2006;118(4):e1237–43.PubMedCrossRef
54.
Gastaut H. A new type of epilepsy: Benign partial epilepsy of childhood with occipital spike-waves. Clin Electroencephalogr. 1982;13:13–22.PubMed
55.
Panayiotopoulos CP. Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: Differentiation from migraine. J Neurol Neurosurg Psychiatry. 1999;57:1371–4.CrossRef
56.
Giroud M, Couillaut G, Arnould S, et al. Epilepsy with rolandic paroxysms and migraine: A nonfortuitous association. Results of a controlled study. Pediatrie. 1989;44:659–64.PubMed
57.
Neut D, Fily A, Cuvellier JC, Vallée L. The prevalence of triggers in pediatric migraine: a questionnaire study in 102 children and adolescents. J Headache Pain. 2012;13(1):61–5.PubMedCentralPubMedCrossRef
58.
Balamurugan E, Aggarwal M, Lamba A, Dang N, Tripathi M. Perceived trigger factors of seizures in persons with epilepsy. Seizure. 2013;22(9):743–7.PubMedCrossRef
59.
Parisi P, Piccioli M, Villa MP, et al. Hypothesis on neurophysiopathological mechanisms linking epilepsy and headache. Med Hypotheses. 2008;70:1150–4.PubMedCrossRef
60.
Verrotti A, Coppola G, Spalice A, Di Fonzo A, Bruschi R, Tozzi E, et al. Peri-ictal and inter-ictal headache in children and adolescents with idiopathic epilepsy: a multicenter cross-sectional study. Childs Nerv Syst. 2011;27(9):1419–23.PubMedCrossRef
61.
Lope RJ, Wong SW, Wu LL. Episodic vomiting and headache in children: consider occipital epilepsy. J Paediatr Child Health. 2010;46(4):204–6.PubMedCrossRef
62.
Papatheophilou R, Jeavons PM, Disney ME. Recurrent abdominal pain: a clinical and electroencephalographic study. Dev Med Child Neurol. 1972;14(1):31–44.PubMedCrossRef
63.
Olmez A, Köse G, Turanli G. Cyclic vomiting with generalized epileptiform discharges responsive to topiramate therapy. Pediatr Neurol. 2006;35(5):348–51.PubMedCrossRef
64.
Chopra SS, Kulkarni SD, Hegde AU, Shah KN. Cyclical vomiting syndrome with bilateral epileptiform discharges. Indian Pediatr. 2011;48(2):143–5.PubMed
65.
Murphy JV, Dehkharghani F. Diagnosis of childhood seizure disorders. Epilepsia. 1994;35 Suppl 2:S7–17.PubMedCrossRef
66.
Vassella F. [Differential diagnosis of cerebral seizures]. Monatsschr Kinderheilkd. 1992;140(7):391–5.PubMed
67.
Sances G, Guaschino E, Perucca P, et al. Migralepsy: A call for revision of the definition. Epilepsia. 2009;50:2487–96.PubMedCrossRef
68.
Kossoff EH, Hatfield LA, Ball KL, et al. Comorbidity of epilepsy and headache in patients with Sturge-Weber syndrome. J Child Neurol. 2005;20:678–82.PubMedCrossRef
69.
Goh S, Butler W, Thiele EA. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology. 2004;63:1457–61.PubMedCrossRef
70.
Klopstock T, May A, Seibel P, et al. Mitochondrial DNA in migraine with aura. Neurology. 1996;46:1735–8.PubMedCrossRef
71.
Gronseth GS, Greenberg MK. The utility of the electroencephalogram in the evaluation of patients presenting with headache: A review of the literature. Neurology. 1995;45:1263–7.PubMedCrossRef
72.
Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12):2215–24.PubMedCrossRef
73.
Hershey AD, Kabbouche MA, Powers SW. Treatment of pediatric and adolescent migraine. Pediatr Ann. 2010;39(7):416–23.PubMedCrossRef
74.
O'Brien HL, Kabbouche MA, Hershey AD. Treatment of acute migraine in the pediatric population. Curr Treat Options Neurol. 2010;12(3):178–85.PubMedCrossRef
75.
Kabbouche MA, Vockell AL, LeCates SL, Powers SW, Hershey AD. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics. 2001;107(4):E62.PubMedCrossRef
76.
Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26(5):541–6.PubMedCrossRef
77.
Larkin G. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med. 1999;6(6):668–70.PubMedCrossRef
78.
Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004;43(2):256–62.PubMedCrossRef
79.
Shrestha M, Singh R, Moreden J, Hayes JE. Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double blind. Arch Intern Med. 1996;156(15):1725–8.PubMedCrossRef
80.
Mathew NT, Kailasam J, Meadors L, Chernyschev O, Gentry P. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache. 2000;40(9):720–3.PubMedCrossRef
81.
Tanen DA, Miller S, French T, Riffenburgh RH. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med. 2003;41(6):847–53.PubMedCrossRef
82.
Shearer P, Riviello J. Generalized convulsive status epilepticus in adults and children: treatment guidelines and protocols. Emerg Med Clin North Am. 2011;29(1):51–64.PubMedCrossRef
83.
Yamamoto LG, Yim GK. The role of intravenous valproic acid in status epilepticus. Pediatr Emerg Care. 2000;16:296–8.PubMedCrossRef
84.
Jacob J, Goadsby PJ, Duncan JS. Use of sumatriptan in postictal migraine headache. Neurology. 1996;47:1104.PubMedCrossRef
85.
Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6, CD010608.PubMed
86.
Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15(10):1013–28.PubMedCrossRef
87.
Freitag FG. Divalproex in the treatment of migraine. Psychopharmacol Bull. 2003;37 suppl 2:98–115.PubMed
88.
Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: Expert opinion, 2005. J Child Neurol. 2005;20 suppl 1:S1–56.PubMed
89.
Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: A randomized controlled trial. JAMA. 2004;291:965–73.PubMedCrossRef
90.
Mathew NT, Rapoport A, Saper J, et al. Efficacy of gabapentin in migraine prophylaxis. Headache. 2001;41:119–28.PubMedCrossRef
91.
Lampl C, Katsarava Z, Diener HC, et al. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry. 2005;76:1730–2.PubMedCrossRef
92.
93.
94.
Di Lorenzo C, Sirianni G, Coppola G, et al. Does migraine improve thorough ketogenic diet? Neurol Sci [Abstr]. 2010;31:S225.
95.
Schnabel TG. An experience with a ketogenic dietary in migraine. Ann Intern Med. 1928;2:341–7.CrossRef
96.
Mauskop A. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia. 2005;25:82–6.PubMedCrossRef
97.
Kossoff EH, Huffman J, Turner Z, et al. Use of the modified Atkins diet for adolescents with chronic daily headache. Cephalalgia. 2010;30:1014–6.PubMed
98.
Brna P, Dooley J, Gordon K, et al. The prognosis of childhood headache: A 20-year follow-up. Arch Pediatr Adolesc Med. 2005;159:1157–60.PubMedCrossRef
99.
Kienbacher C, Wober C, Zesch H, et al. Clinical features, classification and prognosis of migraine and tension-type headache in children and adolescents: A long-term follow-up study. Cephalalgia. 2006;26:820–30.PubMedCrossRef
100.
Shinnar S, Pellock JM. Update on the epidemiology and prognosis of pediatric epilepsy. J Child Neurol. 2002;17 Suppl 1:S4–17.PubMedCrossRef
Metadata
Title
Migraine and Epilepsy in the Pediatric Population
Authors
Christopher B. Oakley
Eric H. Kossoff
Publication date
01-03-2014
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 3/2014
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-013-0402-3

Other articles of this Issue 3/2014

Current Pain and Headache Reports 3/2014 Go to the issue

Neuromodulation (M Gofeld, Section Editor)

Patient Selection for Spinal Cord Stimulators: Mental Health Perspective

Childhood and Adolescent Headache (S Evers, Section Editor)

Primary Headaches in Children Under the Age of 7 Years

Uncommon Headache Syndromes (J Ailani, Section Editor)

Orofacial Pain and Headache: A Review and Look at the Commonalities

Neuromodulation (M Gofeld, Section Editor)

New Horizons in Neuromodulation

Cancer Pain (D Marcus, Section Editor)

Quantifying Psychological Distress among Cancer Patients in Interventions and Scales: A Systematic Review